{"transactions":[{"id":4615083,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Class A Common Stock","published_at":"2026-09-10T21:55:57.000Z","date":"2026-09-08","kind":"sale","planned":true,"acquired":false,"shares":22408,"price":3.5176,"value":78822.3808,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $3.485 to $3.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":2072890,"source":{"system":"sec-edgar","filing":"0001601830-26-000105","document":"wk-form4_1789077354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000160183026000105/wk-form4_1789077354.xml","form_type":"4"}},{"id":683873,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Class A Common Stock","published_at":"2026-08-18T21:44:34.000Z","date":"2026-08-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":80498,"price":3.16,"value":254373.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":2095298,"source":{"system":"sec-edgar","filing":"0002020969-26-000006","document":"wk-form4_1787089472.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000202096926000006/wk-form4_1787089472.xml","form_type":"4"}},{"id":748320,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Class A Common Stock","published_at":"2026-06-05T21:02:57.000Z","date":"2026-06-05","kind":"sale","planned":true,"acquired":false,"shares":23588,"price":3.5806,"value":84459.1928,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $3.56 to $3.62. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":2175796,"source":{"system":"sec-edgar","filing":"0002020969-26-000004","document":"wk-form4_1780693375.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000202096926000004/wk-form4_1780693375.xml","form_type":"4"}},{"id":772565,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Class A Common Stock","published_at":"2026-05-19T21:54:50.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":62701,"price":3.04,"value":190611.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":2199384,"source":{"system":"sec-edgar","filing":"0002020969-26-000002","document":"wk-form4_1779227687.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000202096926000002/wk-form4_1779227687.xml","form_type":"4"}},{"id":849092,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Class A Common Stock","published_at":"2026-03-11T21:41:15.000Z","date":"2026-03-09","kind":"sale","planned":true,"acquired":false,"shares":28298,"price":3.3451,"value":94659.6398,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2025"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $3.32 to $3.405. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":2262085,"source":{"system":"sec-edgar","filing":"0001601830-26-000048","document":"wk-form4_1773265272.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000160183026000048/wk-form4_1773265272.xml","form_type":"4"}},{"id":893765,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Class A Common Stock","published_at":"2026-02-20T00:30:39.000Z","date":"2026-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":14280,"price":3.49,"value":49837.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":2290383,"source":{"system":"sec-edgar","filing":"0001601830-26-000019","document":"wk-form4_1771547436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000160183026000019/wk-form4_1771547436.xml","form_type":"4"}},{"id":912394,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Class A Common Stock","published_at":"2026-02-10T23:18:29.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":10364,"price":3.98,"value":41248.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":2304663,"source":{"system":"sec-edgar","filing":"0001601830-26-000014","document":"wk-form4_1770765506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000160183026000014/wk-form4_1770765506.xml","form_type":"4"}},{"id":912393,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Class A Common Stock","published_at":"2026-02-10T23:18:29.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":30346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This RSU vested immediately upon the grant date."}],"balance_after":2315027,"source":{"system":"sec-edgar","filing":"0001601830-26-000014","document":"wk-form4_1770765506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000160183026000014/wk-form4_1770765506.xml","form_type":"4"}},{"id":912392,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Class A Common Stock","published_at":"2026-02-10T23:18:29.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":1673546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2026 and every three months thereafter."}],"balance_after":2284681,"source":{"system":"sec-edgar","filing":"0001601830-26-000014","document":"wk-form4_1770765506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000160183026000014/wk-form4_1770765506.xml","form_type":"4"}},{"id":958445,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2025-12-29T22:24:36.000Z","date":"2025-12-22","kind":"sale","planned":true,"acquired":false,"shares":124403,"price":4.4098,"value":548592.3494,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $4.30 to $4.48. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":611135,"source":{"system":"sec-edgar","filing":"0001601830-25-000176","document":"wk-form4_1767047073.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000160183025000176/wk-form4_1767047073.xml","form_type":"4"}},{"id":994163,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2025-11-20T00:37:32.000Z","date":"2025-11-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":17584,"price":4.14,"value":72797.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":735538,"source":{"system":"sec-edgar","filing":"0002020969-25-000006","document":"wk-form4_1763599049.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000202096925000006/wk-form4_1763599049.xml","form_type":"4"}},{"id":1005958,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-06T21:23:53.000Z","date":"2025-11-05","kind":"grant","planned":false,"acquired":true,"shares":169851,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to one forty-eighth (1/48th) of the shares subject to the option on December 5, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter."}],"balance_after":169851,"derivative":{"exercise_price":4.96,"expiration_date":"2035-11-05","underlying":"Class A Common Stock","underlying_shares":169851},"source":{"system":"sec-edgar","filing":"0002020969-25-000004","document":"wk-form4_1762464230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000202096925000004/wk-form4_1762464230.xml","form_type":"4"}},{"id":1005957,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2025-11-06T21:23:53.000Z","date":"2025-11-05","kind":"grant","planned":false,"acquired":true,"shares":84925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on February 15, 2026, and every three months thereafter."}],"balance_after":753122,"source":{"system":"sec-edgar","filing":"0002020969-25-000004","document":"wk-form4_1762464230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000202096925000004/wk-form4_1762464230.xml","form_type":"4"}},{"id":1062181,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2025-08-19T22:22:00.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":36599,"price":5.524,"value":202172.876,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares that have been required to be sold by the Issuer to satisfy the tax withholding and remittance obligations in connection with the vesting of restricted stock units."}],"balance_after":668197,"source":{"system":"sec-edgar","filing":"0001601830-25-000131","document":"wk-form4_1755642116.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000160183025000131/wk-form4_1755642116.xml","form_type":"4"}},{"id":1062180,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2025-08-19T22:22:00.000Z","date":"2025-08-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":3789,"price":5.64,"value":21369.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":704796,"source":{"system":"sec-edgar","filing":"0001601830-25-000131","document":"wk-form4_1755642116.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000160183025000131/wk-form4_1755642116.xml","form_type":"4"}},{"id":1143240,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2025-05-19T20:44:24.000Z","date":"2025-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":3796,"price":4.25,"value":16133.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":708585,"source":{"system":"sec-edgar","filing":"0001601830-25-000084","document":"wk-form4_1747687456.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000160183025000084/wk-form4_1747687456.xml","form_type":"4"}},{"id":1282289,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-05T21:50:30.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":420226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter."}],"balance_after":420226,"derivative":{"exercise_price":7.25,"expiration_date":"2035-02-03","underlying":"Class A Common Stock","underlying_shares":420226},"source":{"system":"sec-edgar","filing":"0001628280-25-004086","document":"wk-form4_1738792220.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000162828025004086/wk-form4_1738792220.xml","form_type":"4"}},{"id":1282288,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-05T21:50:30.000Z","date":"2025-02-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":2753,"price":7.25,"value":19959.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":712381,"source":{"system":"sec-edgar","filing":"0001628280-25-004086","document":"wk-form4_1738792220.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000162828025004086/wk-form4_1738792220.xml","form_type":"4"}},{"id":1282287,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-05T21:50:30.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":8049,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This RSU vested immediately upon the grant date."}],"balance_after":715134,"source":{"system":"sec-edgar","filing":"0001628280-25-004086","document":"wk-form4_1738792220.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000162828025004086/wk-form4_1738792220.xml","form_type":"4"}},{"id":1282286,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-05T21:50:30.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":210113,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2025 and every three months thereafter."}],"balance_after":707085,"source":{"system":"sec-edgar","filing":"0001628280-25-004086","document":"wk-form4_1738792220.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000162828025004086/wk-form4_1738792220.xml","form_type":"4"}},{"id":1441078,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-05T21:12:25.000Z","date":"2024-08-01","kind":"grant","planned":false,"acquired":true,"shares":993944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests as to one fourth (1/4th) of the shares subject to the option on July 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter subject to Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":993944,"derivative":{"exercise_price":7.34,"expiration_date":"2034-08-01","underlying":"Class A Common Stock","underlying_shares":993944},"source":{"system":"sec-edgar","filing":"0001601830-24-000106","document":"wk-form4_1722892337.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000160183024000106/wk-form4_1722892337.xml","form_type":"4"}},{"id":1441077,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2024-08-05T21:12:25.000Z","date":"2024-08-01","kind":"grant","planned":false,"acquired":true,"shares":496972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This RSU vests as to one fourth (1/4th) of the units subject to the RSU on August 15, 2025 and one sixteenth (1/16th) every three months thereafter subject to Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":496972,"source":{"system":"sec-edgar","filing":"0001601830-24-000106","document":"wk-form4_1722892337.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000160183024000106/wk-form4_1722892337.xml","form_type":"4"}}]}